시장보고서

상품코드

2092678

암 게놈 패널 및 프로파일링 시장 : 검사 유형별, 기술별, 암 유형별, 최종 용도별, 용도별, 국가별, 지역별 - 업계 분석, 시장 규모, 시장 점유율 및 예측(2026-2033년)

Genomic Cancer Panel and Profiling Market, By Testing Type, By Technology, By Cancer Type, By End-Use, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

발행일: 2026년 06월 | 리서치사: 구분자

AnalystView Market Insights | 페이지 정보: 영문 444 Pages | 배송안내 : 2-3일 (영업일 기준)

가격

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 3,250

￦ 4,841,000

PDF (5 User License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,560

￦ 6,793,000

PDF & Excel (Enterprise User License)

PDF & Excel 보고서를 동일 기업 내 모든 사용자가 사용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,650

￦ 8,417,000

※ 부가세 별도

한글목차

영문목차

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

암 게놈 패널 및 프로파일링 시장 규모는 2025년에 116억 8,070만 달러로 평가되며, 2026-2033년에 CAGR 8.9%로 확대할 것으로 전망되고 있습니다.

유전체 암 패널 및 프로파일링은 환자의 종양 유전적 구성을 파악하기 위한 진단 기술입니다. DNA, RNA 및 기타 유전 물질을 분석하여 암의 증식이나 진행을 유발할 가능성이 있는 변화를 파악합니다. 이 검사를 통해 첨단 염기서열 분석 기술을 활용하여 여러 유전자를 동시에 평가함으로써, 돌연변이, 유전자 융합, 복제수 변이 및 기타 유형의 분자적 변화를 검출할 수 있습니다. 이렇게 얻은 지식은 의료진이 암의 고유한 특성을 더 깊이 이해하고, 보다 적절한 치료 방침을 결정하는 데 도움이 됩니다.

암 유전체 패널 및 프로파일링 시장 - 시장 역학

클라우드 네이티브 애플리케이션에 대한 기업의 수요가 증가하고, 자동화 및 AI 통합이 진전됨에 따라 시장 수요가 확대될 것으로 예상됩니다.

게놈 암 패널 및 프로파일링 시장의 성장을 이끄는 주요 요인 중 하나는 정밀 종양학의 도입 확대입니다. 암 치료는 획일적인 접근 방식에서 벗어나, 개별 환자의 종양 유전적 특성에 맞춘 치료로 전환되고 있습니다. 유전체 프로파일링은 종양 전문의가 암의 진행이나 치료에 영향을 미치며 치료에 활용할 수 있는 돌연변이, 유전자 융합 및 기타 분자 바이오마커를 검출하는 데 도움이 됩니다. 이를 통해 치료 효과를 높이고, 환자의 예후를 개선하며, 효과가 낮은 치료법의 선택을 피할 수 있는 표적 치료법이나 면역 치료법을 특정할 수 있게 됩니다. 또한 전 세계에서 증가하는 암의 부담도 시장 확대에 크게 기여하고 있습니다. 세계보건기구(WHO)에 따르면 2050년까지 전 세계에서 3,500만 건의 신규 암 환자가 진단될 것으로 예측되며, 그 수는 앞으로도 계속 증가할 것으로 전망됩니다.

암 발병률이 높아짐에 따라 의료 시스템에서는 맞춤형 치료 계획을 지원하는 첨단 진단 툴이 점점 더 중요시되고 있습니다. 암 유전체 프로파일링은 의사가 더 조기에 최적의 치료 전략을 파악하고, 시행착오를 통한 치료 결정 과정을 최소화하며, 임상시험 대상 환자 선정을 개선하는 데 도움이 됩니다. 또한 표적 항암제 및 동반 진단제의 활용 가능성이 높아짐에 따라 게놈 검사의 임상적 중요성이 커지고 있으며, 포괄적인 분자 프로파일링은 현대 암 치료에서 점점 더 중요한 요소로 자리 잡고 있습니다.

암 유전체 패널 및 프로파일링 시장은 유전체 염기서열 분석 기술, 특히 차세대 염기서열 분석(NGS)의 끊임없는 발전에 힘입어 성장하고 있습니다. 시퀀싱의 속도, 정확도 및 데이터 분석 능력의 향상으로 인해 암과 관련된 유전적 변이를 규명하는 능력은 최근 수년간 크게 향상되었습니다. 또한 자동화가 진전되면서 검사 프로세스가 합리화되었고, 결과 제공도 더욱 효율적이 되었습니다. 그 결과, 점점 더 많은 의료 서비스 제공자들이 암의 일상적인 진단 및 치료 계획에 유전체 프로파일링을 도입하고 있으며, 이것이 시장 성장을 지원하고 있습니다.

암 유전체 패널 및 프로파일링 시장 - 시장 세분화 분석:

전 세계 게놈 암 패널 및 프로파일링 시장은 검사 유형, 기술, 암 유형, 최종 용도, 응용 분야 및 지역별로 세분화되어 있습니다.

이 시장은 검사 유형에 따라 7가지 범주로 분류됩니다. 구체적으로는 포괄적 유전체 프로파일링(CGP), 표적 유전자 패널, 전유전체 염기서열 분석(WGS), 전엑솜 염기서열 분석(WES), 액체생검 기반 유전체 프로파일링, 고형 생검 기반 유전체 프로파일링 등이 있습니다. 포괄적 유전체 프로파일링(CGP)은 단 한 번의 검사로 종양을 분자 수준에서 상세히 파악할 수 있게 해주기 때문에 유전체 암 패널 및 프로파일링 시장에서 큰 점유율을 차지하고 있습니다. 미리 정의된 제한된 수의 유전자에 초점을 맞추는 표적 유전자 패널과 달리, CGP는 수백 개의 암 관련 유전자를 동시에 분석하여 종양의 유전적 구성에 대해 보다 포괄적인 인사이트를 제공합니다. 이러한 포괄적인 접근 방식을 통해 유전자 변이, 복제수 변이, 유전자 재조합 등 다양한 유전체 변이를 규명할 수 있습니다.

유전체 암 패널 및 프로파일링 시장 - 지역별 분석

북미 시장의 성장은 정밀 의학이 일상적인 암 치료에 점점 더 많이 도입됨에 따라 강력한 지원을 받고 있습니다. 주요 암 연구 기관, 대학 병원 및 전문 암 클리닉에서는 개별 환자에 맞춘 치료 계획을 수립하기 위해 유전체 프로파일링을 더욱 적극적으로 활용하고 있습니다. 의료 제공자, 연구 기관 및 이해관계자들이 협력하여 새로운 게놈 검사를 개발함에 따라 해당 지역의 정밀 종양학 기반이 강화되었으며, 포괄적인 유전체 프로파일링이 임상 현장에서 더욱 널리 채택되고 있습니다. 유럽에서는 액체생검 기술과 첨단 유전체 분석 솔루션의 활용이 확대됨에 따라 시장이 성장하고 있습니다.

의료진은 특히 암 발견, 질환의 경과 관찰 및 치료 효과 평가에 있으며, 기존의 조직 생검을 대체할 수 있는 비침습적인 대안으로서 혈액을 이용한 게놈 검사를 점점 더 많이 활용하고 있습니다. 동시에, 인공지능, 기계학습 및 첨단 생물정보학 툴을 통해 복잡한 게놈 데이터의 분석 및 해석 능력이 향상되고 있습니다. 이러한 기술을 통해 임상의는 보다 신속하고 정확한 정보를 얻을 수 있게 되었으며, 이는 보다 적절한 치료 결정에 도움을 줄 뿐만 아니라 지역 전체에서 유전체 프로파일링의 보급 확대에 기여하고 있습니다.

Genomic cancer panel and profiling is a diagnostic technique to determine the genetic makeup of a patient's tumor. It looks at DNA, RNA and other genetic material to find changes that could be causing the cancer to grow and progress. The test uses advanced sequencing technologies to simultaneously assess multiple genes and is able to detect mutations, gene fusions, copy number variations, and other types of molecular changes. The knowledge gained helps healthcare providers to better understand the unique characteristics of a cancer and make better treatment decisions.

Genomic Cancer Panel and Profiling Market- Market Dynamics

Increasing enterprise demand for cloud-native applications and growing automation, Ai integration are expected to propel market demand

One of the primary factors driving growth in the genomic cancer panel and profiling market is the increasing adoption of precision oncology. Cancer treatment is shifting away from a one-size-fits-all approach toward therapies tailored to the genetic makeup of an individual patient's tumor. Genomic profiling can assist oncologists in detecting actionable mutations, gene fusions and other molecular biomarkers that impact the development and treatment of a cancer. This allows for the identification of targeted therapies and immunotherapies that can increase the effectiveness of treatment and improve patient outcomes and reduce exposure to less effective treatment options. The rising global burden of cancer is also contributing significantly to market expansion. According to the World Health Organization (WHO), 35 million new cancer cases are expected to be diagnosed worldwide by 2050, and the number is expected to continue further.

As cancer incidence grows, healthcare systems are placing greater emphasis on advanced diagnostic tools that support personalized treatment planning. Genomic cancer profiling helps physicians identify the most appropriate therapeutic strategies at an earlier stage, minimizes trial-and-error treatment decisions, and improves patient selection for clinical trials. Furthermore, the growing availability of targeted oncology drugs and companion diagnostics has increased the clinical relevance of genomic testing, making comprehensive molecular profiling an increasingly important component of modern cancer care.

The genomic cancer panel and profiling market is growing with the help of constant improvements in genomic sequencing technologies, especially next-generation sequencing (NGS). The ability to identify genetic changes that are related to cancer has improved greatly over the years with improvements in sequencing speed, accuracy, and data analysis. Automation has also been increased, making the testing processes more streamlined, and the results can be delivered more efficiently. As a result, more and more healthcare providers are integrating genomic profiling into the routine diagnosis and treatment planning for cancer, which is fueling the market growth.

Genomic Cancer Panel and Profiling Market- Segmentation Analysis:

The Global Genomic Cancer Panel and Profiling Market is segmented on the basis of Testing Type, Technology, Cancer Type, End-Use, Application, and Region.

The market is divided into seven categories based on Testing Type: Comprehensive Genomic Profiling (CGP), Targeted Gene Panels, Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), liquid biopsy-based genomic profiling, solid biopsy-based genomic profiling, and others. Comprehensive Genomic Profiling (CGP) holds the substantial share of the genomic cancer panel and profiling market because it provides a detailed molecular understanding of tumors through a single test. Unlike targeted gene panels, which focus on a limited number of predefined genes, CGP analyzes hundreds of cancer-related genes simultaneously, offering a more comprehensive view of a tumor's genetic makeup. This broader approach helps identify a wide range of genomic alterations, including gene mutations, copy number changes, gene rearrangements, etc.

Genomic Cancer Panel and Profiling Market- Geographical Insights

North America's market growth is being strongly supported by the increasing integration of precision medicine into routine cancer care. Leading cancer research institutions, academic medical centers, and specialized oncology clinics are making greater use of genomic profiling to tailor treatment plans to individual patients. Through collaboration between healthcare providers, research organizations and industry stakeholders to develop new genomic testing, the region's precision oncology landscape has been strengthened, driving wider adoption of comprehensive genomic profiling into clinical practice. In Europe, the market is growing because of the increasing use of liquid biopsy technologies and advanced genomic analysis solutions.

Healthcare providers are increasingly turning to blood-based genomic testing as a less invasive alternative to conventional tissue biopsies, particularly for cancer detection, disease monitoring, and evaluating treatment effectiveness. At the same time, artificial intelligence, machine learning, and advanced bioinformatics tools are improving the analysis and interpretation of complex genomic data. These technologies enable clinicians to generate faster and more accurate insights, supporting better-informed treatment decisions and contributing to the growing adoption of genomic profiling across the region.

United States Genomic Cancer Panel and Profiling Market- Key Insights

The United States is the prominent market for genomic cancer panels and profiling, supported by its strong emphasis on precision medicine, well-established healthcare infrastructure, and widespread use of molecular diagnostics in cancer care. As oncology increasingly moves toward biomarker-driven treatment approaches, healthcare providers are making genomic testing a routine part of clinical decision-making. The growing cancer burden is also contributing to demand for advanced diagnostic solutions. According to the American Cancer Society, more than 2 million new cancer cases are expected to be diagnosed annually in the United States, underscoring the need for technologies that can help deliver more personalized and effective treatment strategies. In addition, the rising number of FDA-approved targeted cancer therapies is further increasing the importance of genomic profiling, as these tests help identify patients who are most likely to benefit from specific treatments.

Genomic Cancer Panel and Profiling Market- Competitive Landscape:

The genomic cancer panel and profiling market is highly competitive, with diagnostic companies, sequencing technology providers, biotechnology firms, and specialized molecular testing laboratories all striving to strengthen their presence in the growing precision oncology space. As demand for personalized cancer care continues to rise, companies are investing heavily in expanding their testing portfolios, improving sequencing performance, and advancing bioinformatics tools that can deliver deeper and more clinically meaningful insights into tumor genetics.

A major area of focus is the development of more comprehensive genomic profiling solutions that help clinicians identify actionable mutations and select the most appropriate treatment options for patients. To support this goal, many diagnostic companies are collaborating with pharmaceutical and biotechnology firms to develop companion diagnostics that can determine which patients are most likely to benefit from specific targeted therapies or immunotherapies.

Recent Developments:

In April 2025, Guardant Health announced a long-term partnership with Pfizer aimed at advancing the development and commercialization of precision oncology treatments through its Infinity liquid biopsy platform. The collaboration leverages blood-based genomic testing and circulating tumor DNA (ctDNA) technologies to support biomarker identification.

In May 2025, Illumina strengthened its presence in precision oncology by broadening the availability of its TruSight Oncology Comprehensive assay and enhancing reimbursement support for comprehensive genomic profiling services.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GENOMIC CANCER PANEL AND PROFILING MARKET KEY PLAYERS

Illumina, Inc.
Thermo Fisher Scientific Inc.
F. Hoffmann-La Roche Ltd
QIAGEN N.V.
Agilent Technologies, Inc.
Guardant Health, Inc.
Exact Sciences Corporation
Foundation Medicine, Inc.
Caris Life Sciences
Tempus AI, Inc.
NeoGenomics Laboratories, Inc.
Myriad Genetics, Inc.
Natera, Inc.
BGI Genomics Co., Ltd.
Personalis, Inc.
Others

GLOBAL GENOMIC CANCER PANEL AND PROFILING MARKET, BY TESTING TYPE- MARKET ANALYSIS, 2020-2033

Comprehensive Genomic Profiling (CGP)
Targeted Gene Panels
Whole Genome Sequencing (WGS)
Whole Exome Sequencing (WES)
Others

GLOBAL GENOMIC CANCER PANEL AND PROFILING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020-2033

Next-Generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Fluorescence in Situ Hybridization (FISH)
Microarray Analysis
Others

GLOBAL GENOMIC CANCER PANEL AND PROFILING MARKET, BY CANCER TYPE- MARKET ANALYSIS, 2020-2033

Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Hematological Malignancies
Others

GLOBAL GENOMIC CANCER PANEL AND PROFILING MARKET, BY END-USE- MARKET ANALYSIS, 2020-2033

Hospitals
Clinical Diagnostic Laboratories
CROs
Others

GLOBAL GENOMIC CANCER PANEL AND PROFILING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020-2033

Clinical Diagnostics
Biomarker Discovery
Companion Diagnostics
Drug Discovery & Development
Research Applications
Others

GLOBAL GENOMIC CANCER PANEL AND PROFILING MARKET, BY REGION- MARKET ANALYSIS, 2020-2033

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Denmark
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Taiwan
Vietnam
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Iran
Qatar
Rest of MEA

1. Genomic Cancer Panel and Profiling Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Genomic Cancer Panel and Profiling Market Snippet by Testing Type
- 2.1.2. Genomic Cancer Panel and Profiling Market Snippet by Technology
- 2.1.3. Genomic Cancer Panel and Profiling Market Snippet by Cancer Type
- 2.1.4. Genomic Cancer Panel and Profiling Market Snippet by End-Use
- 2.1.5. Genomic Cancer Panel and Profiling Market Snippet by Application
- 2.1.6. Genomic Cancer Panel and Profiling Market Snippet by Country
- 2.1.7. Genomic Cancer Panel and Profiling Market Snippet by Region
2.2. Competitive Insights

3. Genomic Cancer Panel and Profiling Key Market Trends

3.1. Genomic Cancer Panel and Profiling Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Genomic Cancer Panel and Profiling Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Genomic Cancer Panel and Profiling Market Opportunities
3.4. Genomic Cancer Panel and Profiling Market Future Trends

4. Genomic Cancer Panel and Profiling Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Genomic Cancer Panel and Profiling Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Genomic Cancer Panel and Profiling Market Landscape

6.1. Genomic Cancer Panel and Profiling Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Genomic Cancer Panel and Profiling Market - By Testing Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Testing Type, 2025 & 2033 (%)
- 7.1.2. Comprehensive Genomic Profiling (CGP)
- 7.1.3. Targeted Gene Panels
- 7.1.4. Whole Genome Sequencing (WGS)
- 7.1.5. Whole Exome Sequencing (WES)
- 7.1.6. Others

8. Genomic Cancer Panel and Profiling Market - By Technology

8.1. Overview
- 8.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
- 8.1.2. Next-Generation Sequencing (NGS)
- 8.1.3. Polymerase Chain Reaction (PCR)
- 8.1.4. Fluorescence in Situ Hybridization (FISH)
- 8.1.5. Microarray Analysis
- 8.1.6. Others

9. Genomic Cancer Panel and Profiling Market - By Cancer Type

9.1. Overview
- 9.1.1. Segment Share Analysis, By Cancer Type, 2025 & 2033 (%)
- 9.1.2. Breast Cancer
- 9.1.3. Lung Cancer
- 9.1.4. Colorectal Cancer
- 9.1.5. Prostate Cancer
- 9.1.6. Hematological Malignancies
- 9.1.7. Others

10. Genomic Cancer Panel and Profiling Market - By End-Use

10.1. Overview
- 10.1.1. Segment Share Analysis, By End-Use, 2025 & 2033 (%)
- 10.1.2. Hospitals
- 10.1.3. Clinical Diagnostic Laboratories
- 10.1.4. CROs
- 10.1.5. Others

11. Genomic Cancer Panel and Profiling Market - By Application

11.1. Overview
- 11.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
- 11.1.2. Clinical Diagnostics
- 11.1.3. Biomarker Discovery
- 11.1.4. Companion Diagnostics
- 11.1.5. Drug Discovery & Development
- 11.1.6. Research Applications
- 11.1.7. Others

12. Genomic Cancer Panel and Profiling Market- By Geography

12.1. Introduction
- 12.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
12.2. North America
- 12.2.1. Overview
- 12.2.2. Genomic Cancer Panel and Profiling Key Manufacturers in North America
- 12.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.2.4. North America Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
- 12.2.5. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.2.6. North America Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 12.2.7. North America Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 12.2.8. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.2.9. U.S.
  - 12.2.9.1. Overview
  - 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.2.9.3. U.S. Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.2.9.4. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.2.9.5. U.S. Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.2.9.6. U.S. Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.2.9.7. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.2.10. Canada
  - 12.2.10.1. Overview
  - 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.2.10.3. Canada Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.2.10.4. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.2.10.5. Canada Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.2.10.6. Canada Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.2.10.7. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3. Europe
- 12.3.1. Overview
- 12.3.2. Genomic Cancer Panel and Profiling Key Manufacturers in Europe
- 12.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.3.4. Europe Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
- 12.3.5. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.3.6. Europe Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 12.3.7. Europe Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 12.3.8. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.3.9. Germany
  - 12.3.9.1. Overview
  - 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.9.3. Germany Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.3.9.4. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.3.9.5. Germany Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.3.9.6. Germany Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.3.9.7. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.3.10. UK
  - 12.3.10.1. Overview
  - 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.10.3. UK Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.3.10.4. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.3.10.5. UK Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.3.10.6. UK Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.3.10.7. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.3.11. France
  - 12.3.11.1. Overview
  - 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.11.3. France Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.3.11.4. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.3.11.5. France Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.3.11.6. France Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.3.11.7. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.3.12. Italy
  - 12.3.12.1. Overview
  - 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.12.3. Italy Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.3.12.4. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.3.12.5. Italy Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.3.12.6. Italy Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.3.12.7. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.3.13. Spain
  - 12.3.13.1. Overview
  - 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.13.3. Spain Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.3.13.4. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.3.13.5. Spain Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.3.13.6. Spain Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.3.13.7. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.3.14. The Netherlands
  - 12.3.14.1. Overview
  - 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.14.3. The Netherlands Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.3.14.4. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.3.14.5. The Netherlands Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.3.14.6. The Netherlands Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.3.14.7. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.3.15. Sweden
  - 12.3.15.1. Overview
  - 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.15.3. Sweden Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.3.15.4. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.3.15.5. Sweden Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.3.15.6. Sweden Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.3.15.7. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.3.16. Russia
  - 12.3.16.1. Overview
  - 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.16.3. Russia Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.3.16.4. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.3.16.5. Russia Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.3.16.6. Russia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.3.16.7. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.3.17. Poland
  - 12.3.17.1. Overview
  - 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.17.3. Poland Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.3.17.4. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.3.17.5. Poland Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.3.17.6. Poland Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.3.17.7. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.3.18. Denmark
  - 12.3.18.1. Overview
  - 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.18.3. Denmark Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.3.18.4. Denmark Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.3.18.5. Denmark Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.3.18.6. Denmark Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.3.18.7. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.3.19. Rest of Europe
  - 12.3.19.1. Overview
  - 12.3.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.19.3. Rest of the Europe Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.3.19.4. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.3.19.5. Rest of the Europe Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.3.19.6. Rest of the Europe Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.3.19.7. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4. Asia Pacific (APAC)
- 12.4.1. Overview
- 12.4.2. Genomic Cancer Panel and Profiling Key Manufacturers in Asia Pacific
- 12.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.4.4. APAC Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
- 12.4.5. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.4.6. APAC Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 12.4.7. APAC Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 12.4.8. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.4.9. China
  - 12.4.9.1. Overview
  - 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.9.3. China Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.4.9.4. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.4.9.5. China Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.4.9.6. China Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.4.9.7. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.4.10. India
  - 12.4.10.1. Overview
  - 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.10.3. India Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.4.10.4. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.4.10.5. India Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.4.10.6. India Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.4.10.7. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.4.11. Japan
  - 12.4.11.1. Overview
  - 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.11.3. Japan Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.4.11.4. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.4.11.5. Japan Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.4.11.6. Japan Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.4.11.7. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.4.12. South Korea
  - 12.4.12.1. Overview
  - 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.12.3. South Korea Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.4.12.4. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.4.12.5. South Korea Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.4.12.6. South Korea Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.4.12.7. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.4.13. Australia
  - 12.4.13.1. Overview
  - 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.13.3. Australia Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.4.13.4. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.4.13.5. Australia Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.4.13.6. Australia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.4.13.7. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.4.14. Indonesia
  - 12.4.14.1. Overview
  - 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.14.3. Indonesia Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.4.14.4. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.4.14.5. Indonesia Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.4.14.6. Indonesia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.4.14.7. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.4.15. Thailand
  - 12.4.15.1. Overview
  - 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.15.3. Thailand Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.4.15.4. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.4.15.5. Thailand Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.4.15.6. Thailand Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.4.15.7. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.4.16. Philippines
  - 12.4.16.1. Overview
  - 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.16.3. Philippines Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.4.16.4. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.4.16.5. Philippines Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.4.16.6. Philippines Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.4.16.7. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.4.17. Taiwan
  - 12.4.17.1. Overview
  - 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.17.3. Taiwan Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.4.17.4. Taiwan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.4.17.5. Taiwan Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.4.17.6. Taiwan Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.4.17.7. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.4.18. Vietnam
  - 12.4.18.1. Overview
  - 12.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.18.3. Vietnam Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.4.18.4. Vietnam Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.4.18.5. Vietnam Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.4.18.6. Vietnam Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.4.18.7. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.4.19. Rest of APAC
  - 12.4.19.1. Overview
  - 12.4.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.19.3. Rest of APAC Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.4.19.4. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.4.19.5. Rest of APAC Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.4.19.6. Rest of APAC Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.4.19.7. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5. Latin America (LATAM)
- 12.5.1. Overview
- 12.5.2. Genomic Cancer Panel and Profiling Key Manufacturers in Latin America
- 12.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.5.4. LATAM Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
- 12.5.5. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.5.6. LATAM Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 12.5.7. LATAM Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 12.5.8. LATAM Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.5.9. Brazil
  - 12.5.9.1. Overview
  - 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.9.3. Brazil Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.5.9.4. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.5.9.5. Brazil Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.5.9.6. Brazil Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.5.9.7. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.5.10. Mexico
  - 12.5.10.1. Overview
  - 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.10.3. Mexico Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.5.10.4. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.5.10.5. Mexico Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.5.10.6. Mexico Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.5.10.7. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.5.11. Argentina
  - 12.5.11.1. Overview
  - 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.11.3. Argentina Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.5.11.4. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.5.11.5. Argentina Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.5.11.6. Argentina Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.5.11.7. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.5.12. Colombia
  - 12.5.12.1. Overview
  - 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.12.3. Colombia Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.5.12.4. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.5.12.5. Colombia Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.5.12.6. Colombia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.5.12.7. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.5.13. Rest of LATAM
  - 12.5.13.1. Overview
  - 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.13.3. Rest of LATAM Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.5.13.4. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.5.13.5. Rest of LATAM Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.5.13.6. Rest of LATAM Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.5.13.7. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6. Middle East and Africa
- 12.6.1. Overview
- 12.6.2. Genomic Cancer Panel and Profiling Key Manufacturers in Middle East and Africa
- 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.6.4. Middle East and Africa Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
- 12.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.6.6. Middle East and Africa Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
- 12.6.7. Middle East and Africa Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 12.6.8. Middle East and Africa Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.6.9. Saudi Arabia
  - 12.6.9.1. Overview
  - 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.9.3. Saudi Arabia Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.6.9.4. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.6.9.5. Saudi Arabia Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.6.9.6. Saudi Arabia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.6.9.7. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.6.10. United Arab Emirates
  - 12.6.10.1. Overview
  - 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.10.3. United Arab Emirates Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.6.10.4. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.6.10.5. United Arab Emirates Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.6.10.6. United Arab Emirates Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.6.10.7. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.6.11. Israel
  - 12.6.11.1. Overview
  - 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.11.3. Israel Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.6.11.4. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.6.11.5. Israel Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.6.11.6. Israel Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.6.11.7. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.6.12. Turkey
  - 12.6.12.1. Overview
  - 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.12.3. Turkey Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.6.12.4. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.6.12.5. Turkey Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.6.12.6. Turkey Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.6.12.7. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.6.13. Algeria
  - 12.6.13.1. Overview
  - 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.13.3. Algeria Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.6.13.4. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.6.13.5. Algeria Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.6.13.6. Algeria Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.6.13.7. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.6.14. Egypt
  - 12.6.14.1. Overview
  - 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.14.3. Egypt Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.6.14.4. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.6.14.5. Egypt Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.6.14.6. Egypt Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.6.14.7. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.6.15. Iran
  - 12.6.15.1. Overview
  - 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.15.3. Iran Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.6.15.4. Iran Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.6.15.5. Iran Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.6.15.6. Iran Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.6.15.7. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.6.16. Qatar
  - 12.6.16.1. Overview
  - 12.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.16.3. Qatar Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.6.16.4. Qatar Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.6.16.5. Qatar Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.6.16.6. Qatar Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.6.16.7. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.6.17. Rest of MEA
  - 12.6.17.1. Overview
  - 12.6.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.17.3. Rest of MEA Market Size and Forecast, By Testing Type, 2020 - 2033 (US$ Million)
  - 12.6.17.4. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 12.6.17.5. Rest of MEA Market Size and Forecast, By Cancer Type, 2020 - 2033 (US$ Million)
  - 12.6.17.6. Rest of MEA Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  - 12.6.17.7. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)

13. Key Vendor Analysis- Genomic Cancer Panel and Profiling Industry

13.1. Competitive Benchmarking
- 13.1.1. Competitive Dashboard
- 13.1.2. Competitive Positioning
13.2. Company Profiles
- 13.2.1. Illumina, Inc.
- 13.2.2. Thermo Fisher Scientific Inc.
- 13.2.3. F. Hoffmann-La Roche Ltd
- 13.2.4. QIAGEN N.V.
- 13.2.5. Agilent Technologies, Inc.
- 13.2.6. Guardant Health, Inc.
- 13.2.7. Exact Sciences Corporation
- 13.2.8. Foundation Medicine, Inc.
- 13.2.9. Caris Life Sciences
- 13.2.10. Tempus AI, Inc.
- 13.2.11. NeoGenomics Laboratories, Inc.
- 13.2.12. Myriad Genetics, Inc.
- 13.2.13. Natera, Inc.
- 13.2.14. BGI Genomics Co., Ltd.
- 13.2.15. Personalis, Inc.
- 13.2.16. Others

14. 360 Degree Analyst View

15. Appendix

15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us

암 게놈 패널 및 프로파일링 시장 : 검사 유형별, 기술별, 암 유형별, 최종 용도별, 용도별, 국가별, 지역별 - 업계 분석, 시장 규모, 시장 점유율 및 예측(2026-2033년)

Genomic Cancer Panel and Profiling Market, By Testing Type, By Technology, By Cancer Type, By End-Use, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

암 유전체 패널 및 프로파일링 시장 - 시장 세분화 분석:

목차

제1장 암 게놈 패널 및 프로파일링 시장 개요

제2장 개요

제3장 암 게놈 패널 및 프로파일링 주요 시장 동향

제4장 암 게놈 패널 및 프로파일링 산업 분석

제5장 암 게놈 패널 및 프로파일링 시장 : 높아지는 지정학적 긴장의 영향

제6장 암 게놈 패널 및 프로파일링 시장 구도

제7장 암 게놈 패널 및 프로파일링 시장 : 테스트 유형별

제8장 암 게놈 패널 및 프로파일링 시장 : 기술별

제9장 암 게놈 패널 및 프로파일링 시장 : 암 유형별

제10장 암 게놈 패널 및 프로파일링 시장 : 최종 사용별

제11장 암 게놈 패널 및 프로파일링 시장 : 용도별

제12장 암 게놈 패널 및 프로파일링 시장 : 지역별

제13장 주요 벤더 분석 : 암 게놈 패널 및 프로파일링 산업

제14장 AnalystView의 전방위 전망